https://www.semanticscholar.org/topic/nusinersen-Injection-%5BSpinraza%5D/11639599
nusinersen Injection [Spinraza] | Semantic Scholar
nusinerseninjectionspinrazasemanticscholar
https://www.servicesaustralia.gov.au/pb334
Spinal muscular atrophy adult - nusinersen or risdiplam - initial authority application form...
Use this form to apply for initial PBS-subsidised treatment with nusinersen or risdiplam for patients aged 19 years or over with spinal muscular atrophy.
spinal muscular atrophyadultnusinersen
https://www.medlineplus.gov/druginfo/meds/a617010.html
Nusinersen Injection: MedlinePlus Drug Information
Nusinersen Injection: learn about side effects, dosage, special precautions, and more on MedlinePlus
nusinerseninjectionmedlineplusdruginformation
https://www.nice.org.uk/search?q=Nusinersen
Nusinersen | Search results | NICE
search resultsnusinersennice
https://www.stjude.org/care-treatment/clinical-trials/devote-spinal-muscular-atrophy.html
DEVOTE: Study of Nusinersen in Children with Spinal Muscular Atrophy | St. Jude Care & Treatment
This is a study to find the best dose of nusinersen (Spinraza) that will improve muscle function in patients with spinal muscular atrophy. View eligibility.
https://www.financialcontent.com/article/gnwcq-2025-1-23-fda-and-ema-accept-applications-for-higher-dose-regimen-of-nusinersen-in-sma
FDA and EMA Accept Applications for Higher Dose Regimen of Nusinersen in SMA | FinancialContent
Applications are based on data from the DEVOTE study, which demonstrate the potential for the investigational higher dose regimen of nusinersen to advance the...
https://www.lawinsider.com/contracts/gyPcaIOm0kT
SPINRAZA (NUSINERSEN) MANAGED ACCESS AGREEMENT (MAA) | Law Insider
SPINRAZA (NUSINERSEN) MANAGED ACCESS AGREEMENT (MAA) filed on May 19th, 2020
managed accessspinrazanusinersenagreementmaa
https://www.nice.org.uk/guidance/ta588/informationforpublic
Information for the public | Nusinersen for treating spinal muscular atrophy | Guidance | NICE
Evidence-based recommendations on nusinersen (Spinraza) for treating spinal muscular atrophy in children and adults
information for the publicspinal muscular atrophynusinersen
https://www.preprints.org/manuscript/202506.2242
Neuronal Pentraxin 2 as a Potential Biomarker for Nusinersen Therapy Response in Adults with Spinal...
Background: The treatment landscape for spinal muscular atrophy (SMA) has changed significantly with the approval of gene-based therapies such as nusinersen...